We believe this site might serve you best:

United States

United States

Language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

Our website does not fully support your browser.

We've detected that you are using an older version of Internet Explorer. Your commerce experience may be limited. Please update your browser to Internet Explorer 11 or above.

Citations Search

Sort By:

J. Mol. Diagn. 19, 162-168. A Comparison of Cell-Free DNA Isolation Kits: Isolation and Quantification of Cell-Free DNA in Plasma. 2017

Sorber, L., Zwaenepoel, K., Deschoolmeester, V., Roeyen, G., Lardon, F., Rolfo, C. and Pauwels, P.

Notes: The authors present two highly efficient isolation kits for cfDNA isolation, of which the Maxwell® RSC ccfDNA Plasma Kit has the advantage of a fully automated protocol over the labor-intensive QIA kit. (4773)

Expand Full Notes »

Nat. Commun. 7, 13665. Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer. 2016

Van Emburgh, B.O., Arena, S., Siravegna, G., Lazzari, L., Crisafulli, G., Corti, G., Mussolin, B., Baldi, F., Buscarino, M., Bartolini, A., Valtorta, E., Vidal, J., Bellosillo, B., Germano, G., Pietrantonio, F., Ponzetti, A., Albanell, J., Siena, S., Sartore-Bianchi, A., Di Nicolantonio, F., Montagut, C. and Bardelli, A.

Notes: The authors purified ctDNA from 1ml plasma using the Maxwell® RSC ccfDNA Plasma Kit with the Maxwell® RSC Instrument. Cell line mismatch repair deficiency was confirmed by the MSI Analysis System, Version 1.2. Cell line authentication was performed using the Cell ID™ and GenePrint® 10 Systems. DNA from cultured and treated cells were purified with the Wizard® SV and SV 96 Genomic DNA Purification Systems. Cetuximab-treated cells were measured for viability with the CellTiter-Glo® Luminescent Cell Viability Assay. (4777)

Expand Full Notes »

Lung Cancer 107, 100-107. Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients. 2016

Sorber, L., Zwaenepoel, K., Deschoolmeester, V., Van Schil, P.E., Van Meerbeeck, J., Lardon, F., Rolfo, C. and Pauwels, P.

Notes: The authors purified ctDNA from blood plasma using the Maxwell® RSC ccfDNA Plasma Kit and Maxwell® RSC Instrument. DNA was used in a study to compare mutation detection across several technologies including qPCR, dPCR, BEAMing and NGS.  (4774)

Expand Full Notes »

Clin. Can. Res. 23(10), 2414-2422. Heterogeneity of acquired resistance to anti-EGFR monoclonal antibodies in patients with metastatic colorectal cancer. 2016

Pietrantonio, F., Vernieri, C., Siravegna, G., Mennitto, A., Berenato, R., Perrone, F., Gloghini, A., Tamborini, E., Lonardi, S., Morano, F., Picciani, B., Busico, A., Volpi, C.C., Martinetti, A., Battaglin, F., Bossi, I., Pellegrinelli, A., Milione, M., Cremolini, C., Di Bartolomeo, M., Bardelli, A. and de Braud, F.

Notes: The authors purified ctDNA from plasma using the Maxwell® RSC ccfDNA Plasma Kit with the Maxwell® RSC Instrument. ddPCR was performed to determine mutant allele frequencies. (4776)

Expand Full Notes »